Clinical, Radiological and Microbiological Outcomes of Implants With Two Different Connection Configurations, a Split-mouth RCT.

NCT ID: NCT03528330

Last Updated: 2018-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-08

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study designed as a randomized controlled split-mouth trial will be conducted at the Dental Clinic of the University of Valencia. The aim will be to assess differences in clinical, radiological and microbiological outcomes between implants with 2 different connections: internal hexagon and conical connection. Following the premises, to minimize the bias related to prosthetic phase and maximize the effect of connections on MBL changes, a 1abutment-1time protocol will be used.

The study hypothesis is that there will be no statistically significant differences between both implant connections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Loss, Alveolar Dental Implant Failed

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Internal hexagon connection

Small flaps will be elevated to reduce any kind of injury on the periosteum and maintain the blood supply during the healing period.

Patients will receive 2 implants. One implant (assigned randomly) will have internal hexagon connection.

The Internal Hex (IH) implant has a 2.5mm internal hexagon and a 90° cone. The platform diameter is Ø3.5mm.

Group Type ACTIVE_COMPARATOR

Rehabilitation with dental implant with internal hexagon connection

Intervention Type DEVICE

All patients will receive an implant with internal hexagon connection. All implants will be10 mm in length and 3.75 mm in diameter. Implants will be inserted slightly subcrestal. Bone levels will be measured using a calibrated probe.

Torque insertion will be assed using W\&H machine Once inserted, implants will be connected to smart pegs to test primary stability.

A periapical x-ray will be done after the operation. Thereafter, a specific coping for digital impression will be connected to the implant and a digital impression will be taken. Aim of this procedure will be to produce a screw retained definitive zirconia prosthesis to be adapted at the time of second surgery

Conical connection

Small flaps will be elevated to reduce any kind of injury on the periosteum and maintain the blood supply during the healing period.

Patients will receive 2 implants. One implant (assigned randomly) will have internal hexagon connection.

The Conical Standard (CS) implant has a 2.5mm internal hexagon and 22° cone. The platform diameter is Ø3.1mm.

Group Type EXPERIMENTAL

Rehabilitation with dental implant with conical connection

Intervention Type DEVICE

All patients will receive an implant with conical connection. All implants will be10 mm in length and 3.75 mm in diameter. Implants will be inserted slightly subcrestal. Bone levels will be measured using a calibrated probe.

Torque insertion will be assed using W\&H machine Once inserted, implants will be connected to smart pegs to test primary stability.

A periapical x-ray will be done after the operation. Thereafter, a specific coping for digital impression will be connected to the implant and a digital impression will be taken. Aim of this procedure will be to produce a screw retained definitive zirconia prosthesis to be adapted at the time of second surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rehabilitation with dental implant with internal hexagon connection

All patients will receive an implant with internal hexagon connection. All implants will be10 mm in length and 3.75 mm in diameter. Implants will be inserted slightly subcrestal. Bone levels will be measured using a calibrated probe.

Torque insertion will be assed using W\&H machine Once inserted, implants will be connected to smart pegs to test primary stability.

A periapical x-ray will be done after the operation. Thereafter, a specific coping for digital impression will be connected to the implant and a digital impression will be taken. Aim of this procedure will be to produce a screw retained definitive zirconia prosthesis to be adapted at the time of second surgery

Intervention Type DEVICE

Rehabilitation with dental implant with conical connection

All patients will receive an implant with conical connection. All implants will be10 mm in length and 3.75 mm in diameter. Implants will be inserted slightly subcrestal. Bone levels will be measured using a calibrated probe.

Torque insertion will be assed using W\&H machine Once inserted, implants will be connected to smart pegs to test primary stability.

A periapical x-ray will be done after the operation. Thereafter, a specific coping for digital impression will be connected to the implant and a digital impression will be taken. Aim of this procedure will be to produce a screw retained definitive zirconia prosthesis to be adapted at the time of second surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* able to sign an informed consent form
* aged 25 years or more
* Any patient requiring two implant-supported crowns in the lower or upper jaw
* Kennedy class I, II, and III;
* teeth extracted at least 6 months before implant placement;
* sufficient bone volumes to accommodate dental implants without augmentation procedure

Exclusion Criteria

* General medical and/or psychiatric contraindications to implant surgery,
* Pregnancy or nursing,
* Heavy smoking (more than 10 cigarettes/day),
* Treatment with anticoagulant drugs (International Normalized Ratio under 1.8), bisphosphonates, steroid therapy or anticonvulsants drugs.
* No regenerated bone
* Untreated Periodontal disease and inability of the patient to maintain reasonable oral hygiene according to study requirements.
* Patients with history of alcohol, narcotics or drug abuse. (Alcoholism: more than two bottles of beer per day)
* Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment, or who have been administered radiotherapy in the last 5 years. (Patients through at any time received radiotherapy to the head and neck region should be excluded anyway.)
* Metabolic bone disorders
* Uncontrolled bleeding disorders such as: hemophilia, thrombocytopenia, granulocytopenia.
* Degenerative diseases.
* Osteoradionecrosis.
* Renal failure.
* Organ transplant recipients.
* HIV positive.
* Malignant diseases.
* Diseases that compromise the immune system.
* Unbalanced diabetes mellitus. (HbA1c above 6.5), Uncontrolled endocrine diseases
* Psychotic diseases.
* Hypersensitivity to one of the components of the implant in general and titanium in particular.
* Women who are pregnant or lactating.
* Lack of patient cooperation.
* Parafunctional habits, such as Bruxism or Temporomandibular joint disease.
* Various pathologies of the oral mucosa for example: Benign mucous pemphigoid, desquamative ginigivitis, erosive lichen planus, malignancy of oral cavity, bolus erosive diseases of the oral mucosa.
Minimum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Valencia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Peñarrocha Oltra

Assistanat Postdoctoral Lecturer (Profesor Ayudante Doctor)

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clínica Odontológica de la Universitat de Valencia, Fundación Lluis Alcanyis

Valencia, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Peñarrocha Oltra

Role: CONTACT

649952560

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Peñarrocha Oltra

Role: primary

649952560

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H1506438439563

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Connective Tissue Graft Versus Collagen Matrix
NCT04210596 ACTIVE_NOT_RECRUITING NA